دورية أكاديمية
The Role of Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Ratio in Synovial Fluid as a Potential Marker for Periprosthetic Osteolysis Following Total Ankle Arthroplasty.
| العنوان: | The Role of Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Ratio in Synovial Fluid as a Potential Marker for Periprosthetic Osteolysis Following Total Ankle Arthroplasty. |
|---|---|
| المؤلفون: | Lee GW; Department of Orthopedic Surgery, Chonnam National University Hospital, Gwangju, Korea.; Department of Orthopedic Surgery, Chonnam National University Medical School, Gwangju, Korea., Song JE; Department of Orthopedic Surgery, Chonnam National University Hospital, Gwangju, Korea., Han JE; Department of Orthopedic Surgery, Chonnam National University Hospital, Gwangju, Korea., Kim NS; Department of Pharmacology, Chonnam National University Medical School, Gwangju, Korea., Lee KB; Department of Orthopedic Surgery, Chonnam National University Hospital, Gwangju, Korea.; Department of Orthopedic Surgery, Chonnam National University Medical School, Gwangju, Korea. |
| المصدر: | Clinics in orthopedic surgery [Clin Orthop Surg] 2024 Aug; Vol. 16 (4), pp. 661-668. Date of Electronic Publication: 2024 Jun 07. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Korean Orthopaedic Association Country of Publication: Korea (South) NLM ID: 101505087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-4408 (Electronic) Linking ISSN: 2005291X NLM ISO Abbreviation: Clin Orthop Surg Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Seoul : Korean Orthopaedic Association |
| مواضيع طبية MeSH: | Synovial Fluid*/metabolism , Synovial Fluid*/chemistry , Osteolysis*/metabolism , Osteolysis*/etiology , RANK Ligand*/metabolism , Arthroplasty, Replacement, Ankle*/adverse effects , Osteoprotegerin*/metabolism , Osteoprotegerin*/analysis , Biomarkers*/metabolism , Biomarkers*/analysis, Humans ; Male ; Female ; Aged ; Middle Aged ; Aged, 80 and over ; Cytokines/metabolism ; Cytokines/analysis ; Reoperation |
| مستخلص: | Background: Periprosthetic osteolysis is a prevalent complication following total ankle arthroplasty (TAA), implicating various cytokines in osteoclastogenesis as pivotal in this process. This study aimed to evaluate the relationship between osteolysis and the concentrations of osteoclastogenesis-related cytokines in synovial fluid and investigate its clinical value following TAA. Methods: Synovial fluid samples from 23 ankles that underwent revision surgery for osteolysis following TAA were analyzed as the osteolysis group. As a control group, we included synovial fluid samples obtained from 23 ankles during primary TAA for osteoarthritis. The receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) ratio in these samples was quantified using sandwich enzyme-linked immunosorbent assay techniques, and a bead-based multiplex immunoassay facilitated the detection of specific osteoclastogenesis-related cytokines. Results: RANKL levels averaged 487.9 pg/mL in 14 of 23 patients in the osteolysis group, with no detection in the control group's synovial fluid. Conversely, a significant reduction in OPG levels was observed in the osteolysis group ( p = 0.002), resulting in a markedly higher mean RANKL/OPG ratio (0.23) relative to controls ( p = 0.020). Moreover, the osteolysis group had increased concentrations of various osteoclastogenesis-related cytokines (tumor necrosis factor-α, interleukin [IL]-1β, IL-6, IL-8, IP-10, and monocyte chemotactic protein-1) in the synovial fluid relative to the control group. Conclusions: Our results demonstrated that periprosthetic osteolysis was associated with osteoclastogenesis activation through an elevated RANKL/OPG ratio following TAA. We assume that RANKL and other osteoclastogenesis-related cytokines in the synovial fluid have clinical value as a potential marker for the development and progression of osteolysis following TAA. Competing Interests: CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported. (Copyright © 2024 by The Korean Orthopaedic Association.) |
| References: | J Bone Joint Surg Br. 2003 Nov;85(8):1202-6. (PMID: 14653608) Acta Orthop Scand. 2001 Oct;72(5):491-8. (PMID: 11728077) J Clin Med. 2019 Dec 01;8(12):. (PMID: 31805704) Orthop Clin North Am. 2023 Jan;54(1):109-119. (PMID: 36402507) Artif Organs. 2009 Jul;33(7):538-43. (PMID: 19566730) Int Orthop. 2021 May;45(5):1223-1231. (PMID: 33822272) Bone. 2012 Sep;51(3):546-52. (PMID: 22627031) Physiol Res. 2007;56(4):455-462. (PMID: 16925460) Clin Podiatr Med Surg. 2013 Apr;30(2):157-70. (PMID: 23465806) Foot Ankle Int. 2021 Feb;42(2):230-242. (PMID: 33345610) J Bone Joint Surg Am. 2022 Aug 17;104(16):1483-1491. (PMID: 35726878) J Bone Joint Surg Br. 2012 Jan;94(1):10-5. (PMID: 22219240) Biomaterials. 2010 Jan;31(1):77-82. (PMID: 19781765) Arch Orthop Trauma Surg. 2022 Dec;142(12):3697-3704. (PMID: 34086075) J Bone Joint Surg Am. 2022 May 18;104(10):881-888. (PMID: 35290251) Foot Ankle Int. 2015 Feb;36(2):143-50. (PMID: 25201330) Hip Int. 2015 Jul-Aug;25(4):355-60. (PMID: 25952921) Foot Ankle Int. 2016 Feb;37(2):157-64. (PMID: 26429548) Bioengineering (Basel). 2022 Dec 04;9(12):. (PMID: 36550970) J Orthop Res. 2008 Jan;26(1):106-16. (PMID: 17729302) Bone Joint J. 2019 Jun;101-B(6):695-701. (PMID: 31154845) J Bone Joint Surg Am. 2022 Aug 3;104(15):1334-1340. (PMID: 35930380) Bone Joint J. 2021 Apr;103-B(4):696-703. (PMID: 33789488) Foot Ankle Surg. 2022 Dec;28(8):1183-1193. (PMID: 35872118) Clin Orthop Relat Res. 1995 Feb;(311):3-20. (PMID: 7634588) Foot Ankle Int. 2022 May;43(5):609-619. (PMID: 35073771) Front Cell Dev Biol. 2023 Mar 24;11:1123753. (PMID: 37035243) Foot Ankle Clin. 2017 Jun;22(2):267-275. (PMID: 28502348) J Funct Biomater. 2017 Sep 22;8(4):. (PMID: 28937598) |
| فهرسة مساهمة: | Keywords: Osteolysis; Osteoprotegerin; RANK ligand; Synovial fluid; Total ankle arthroplasty |
| المشرفين على المادة: | 0 (RANK Ligand) 0 (Osteoprotegerin) 0 (Biomarkers) 0 (TNFSF11 protein, human) 0 (Cytokines) |
| تواريخ الأحداث: | Date Created: 20240802 Date Completed: 20240802 Latest Revision: 20240803 |
| رمز التحديث: | 20240803 |
| مُعرف محوري في PubMed: | PMC11262952 |
| DOI: | 10.4055/cios23411 |
| PMID: | 39092303 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2005-4408 |
|---|---|
| DOI: | 10.4055/cios23411 |